Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Avoro Capital Advisors Llc
Over the trailing 90 days, Avoro Capital Advisors Llc (Director at Scribe Therapeutics, Inc.) bought $61.3M of stock across 2 companies, per 6 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 6 transactions · CIK 1633313
- Net activity
- +$61.3M ($61.3M bought · $0 sold)
By Company (Trailing 90 Days)
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-28 | SCTX | Buy | 7.9K | $144K | Open market or private purchase |
| 2026-07-24 | SCTX | Buy | 2.3M | $35.0M | Open market or private purchase |
| 2026-07-24 | SCTX | Buy | 50.0K | $1.1M | Open market or private purchase |
| 2026-07-23 | SCTX | Buy | 14.7K | $0 | Grant, award or other acquisition |
| 2026-06-12 | WHWK | Buy | 38.0K | $0 | Grant, award or other acquisition |
| 2026-05-12 | WHWK | Buy | 6.4M | $25.0M | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Avoro's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.